nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafcillin—CYP1A2—Anagrelide—hematologic cancer	0.0762	0.109	CbGbCtD
Nafcillin—CYP1A2—Carmustine—hematologic cancer	0.04	0.0572	CbGbCtD
Nafcillin—CYP1A2—Methoxsalen—hematologic cancer	0.034	0.0486	CbGbCtD
Nafcillin—CYP1A2—Bortezomib—hematologic cancer	0.0324	0.0462	CbGbCtD
Nafcillin—CYP1A2—Daunorubicin—hematologic cancer	0.031	0.0442	CbGbCtD
Nafcillin—CYP1A2—Alitretinoin—hematologic cancer	0.0303	0.0433	CbGbCtD
Nafcillin—CYP1A2—Thalidomide—hematologic cancer	0.0282	0.0403	CbGbCtD
Nafcillin—CYP3A4—Bexarotene—hematologic cancer	0.0277	0.0395	CbGbCtD
Nafcillin—CYP3A4—Lomustine—hematologic cancer	0.0257	0.0367	CbGbCtD
Nafcillin—CYP3A4—Busulfan—hematologic cancer	0.0257	0.0367	CbGbCtD
Nafcillin—CYP1A2—Dacarbazine—hematologic cancer	0.0243	0.0346	CbGbCtD
Nafcillin—CYP1A2—Imatinib—hematologic cancer	0.0237	0.0339	CbGbCtD
Nafcillin—CYP3A4—Thiotepa—hematologic cancer	0.0229	0.0328	CbGbCtD
Nafcillin—CYP1A2—Dasatinib—hematologic cancer	0.019	0.0272	CbGbCtD
Nafcillin—CYP3A4—Methoxsalen—hematologic cancer	0.0178	0.0255	CbGbCtD
Nafcillin—CYP3A4—Bortezomib—hematologic cancer	0.017	0.0242	CbGbCtD
Nafcillin—CYP3A4—Daunorubicin—hematologic cancer	0.0162	0.0232	CbGbCtD
Nafcillin—SLC22A6—Methotrexate—hematologic cancer	0.0154	0.022	CbGbCtD
Nafcillin—CYP3A4—Cytarabine—hematologic cancer	0.0143	0.0204	CbGbCtD
Nafcillin—CYP3A4—Teniposide—hematologic cancer	0.0141	0.0201	CbGbCtD
Nafcillin—CYP3A4—Ifosfamide—hematologic cancer	0.013	0.0186	CbGbCtD
Nafcillin—CYP3A4—Imatinib—hematologic cancer	0.0124	0.0177	CbGbCtD
Nafcillin—CYP1A2—Etoposide—hematologic cancer	0.0119	0.0169	CbGbCtD
Nafcillin—CYP3A4—Ruxolitinib—hematologic cancer	0.0117	0.0167	CbGbCtD
Nafcillin—CYP3A4—Nilotinib—hematologic cancer	0.0113	0.0161	CbGbCtD
Nafcillin—CYP3A4—Vinorelbine—hematologic cancer	0.0112	0.016	CbGbCtD
Nafcillin—CYP3A4—Triamcinolone—hematologic cancer	0.0102	0.0146	CbGbCtD
Nafcillin—CYP3A4—Dasatinib—hematologic cancer	0.00998	0.0143	CbGbCtD
Nafcillin—CYP3A4—Mitoxantrone—hematologic cancer	0.00986	0.0141	CbGbCtD
Nafcillin—CYP3A4—Betamethasone—hematologic cancer	0.00879	0.0126	CbGbCtD
Nafcillin—CYP3A4—Prednisolone—hematologic cancer	0.00867	0.0124	CbGbCtD
Nafcillin—CYP3A4—Prednisone—hematologic cancer	0.00819	0.0117	CbGbCtD
Nafcillin—CYP3A4—Irinotecan—hematologic cancer	0.00776	0.0111	CbGbCtD
Nafcillin—CYP3A4—Vinblastine—hematologic cancer	0.0069	0.00986	CbGbCtD
Nafcillin—CYP3A4—Vincristine—hematologic cancer	0.00678	0.00969	CbGbCtD
Nafcillin—CYP3A4—Etoposide—hematologic cancer	0.00622	0.00888	CbGbCtD
Nafcillin—CYP3A4—Dexamethasone—hematologic cancer	0.00511	0.0073	CbGbCtD
Nafcillin—CYP3A4—Doxorubicin—hematologic cancer	0.00424	0.00606	CbGbCtD
Nafcillin—Rash—Bleomycin—hematologic cancer	9.54e-05	0.000321	CcSEcCtD
Nafcillin—Pain—Cisplatin—hematologic cancer	9.53e-05	0.00032	CcSEcCtD
Nafcillin—Dermatitis—Bleomycin—hematologic cancer	9.53e-05	0.00032	CcSEcCtD
Nafcillin—Hypersensitivity—Ifosfamide—hematologic cancer	9.53e-05	0.00032	CcSEcCtD
Nafcillin—Vomiting—Vinorelbine—hematologic cancer	9.47e-05	0.000318	CcSEcCtD
Nafcillin—Body temperature increased—Gemcitabine—hematologic cancer	9.45e-05	0.000318	CcSEcCtD
Nafcillin—Renal failure—Methotrexate—hematologic cancer	9.43e-05	0.000317	CcSEcCtD
Nafcillin—Neutropenia—Epirubicin—hematologic cancer	9.41e-05	0.000316	CcSEcCtD
Nafcillin—Angioedema—Betamethasone—hematologic cancer	9.41e-05	0.000316	CcSEcCtD
Nafcillin—Angioedema—Dexamethasone—hematologic cancer	9.41e-05	0.000316	CcSEcCtD
Nafcillin—Diarrhoea—Thalidomide—hematologic cancer	9.41e-05	0.000316	CcSEcCtD
Nafcillin—Rash—Vinorelbine—hematologic cancer	9.39e-05	0.000316	CcSEcCtD
Nafcillin—Dermatitis—Vinorelbine—hematologic cancer	9.38e-05	0.000315	CcSEcCtD
Nafcillin—Stomatitis—Methotrexate—hematologic cancer	9.35e-05	0.000314	CcSEcCtD
Nafcillin—Hypersensitivity—Vincristine—hematologic cancer	9.29e-05	0.000312	CcSEcCtD
Nafcillin—Malaise—Dexamethasone—hematologic cancer	9.29e-05	0.000312	CcSEcCtD
Nafcillin—Malaise—Betamethasone—hematologic cancer	9.29e-05	0.000312	CcSEcCtD
Nafcillin—Anaphylactic shock—Triamcinolone—hematologic cancer	9.26e-05	0.000311	CcSEcCtD
Nafcillin—Pruritus—Alitretinoin—hematologic cancer	9.26e-05	0.000311	CcSEcCtD
Nafcillin—Eosinophilia—Doxorubicin—hematologic cancer	9.22e-05	0.00031	CcSEcCtD
Nafcillin—Feeling abnormal—Cisplatin—hematologic cancer	9.19e-05	0.000309	CcSEcCtD
Nafcillin—Pruritus—Ifosfamide—hematologic cancer	9.15e-05	0.000308	CcSEcCtD
Nafcillin—Haematuria—Methotrexate—hematologic cancer	9.15e-05	0.000307	CcSEcCtD
Nafcillin—Shock—Triamcinolone—hematologic cancer	9.11e-05	0.000306	CcSEcCtD
Nafcillin—Nausea—Bortezomib—hematologic cancer	9.06e-05	0.000304	CcSEcCtD
Nafcillin—Hypersensitivity—Irinotecan—hematologic cancer	9.05e-05	0.000304	CcSEcCtD
Nafcillin—Hypersensitivity—Mitoxantrone—hematologic cancer	9.05e-05	0.000304	CcSEcCtD
Nafcillin—Vomiting—Thiotepa—hematologic cancer	9.04e-05	0.000304	CcSEcCtD
Nafcillin—Diarrhoea—Carmustine—hematologic cancer	9.04e-05	0.000304	CcSEcCtD
Nafcillin—Nausea—Bleomycin—hematologic cancer	8.99e-05	0.000302	CcSEcCtD
Nafcillin—Rash—Thiotepa—hematologic cancer	8.96e-05	0.000301	CcSEcCtD
Nafcillin—Dermatitis—Thiotepa—hematologic cancer	8.96e-05	0.000301	CcSEcCtD
Nafcillin—Diarrhoea—Alitretinoin—hematologic cancer	8.95e-05	0.000301	CcSEcCtD
Nafcillin—Agranulocytosis—Methotrexate—hematologic cancer	8.95e-05	0.000301	CcSEcCtD
Nafcillin—Diarrhoea—Ifosfamide—hematologic cancer	8.85e-05	0.000297	CcSEcCtD
Nafcillin—Pancytopenia—Doxorubicin—hematologic cancer	8.85e-05	0.000297	CcSEcCtD
Nafcillin—Nausea—Vinorelbine—hematologic cancer	8.84e-05	0.000297	CcSEcCtD
Nafcillin—Renal failure—Epirubicin—hematologic cancer	8.82e-05	0.000297	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Etoposide—hematologic cancer	8.82e-05	0.000296	CcSEcCtD
Nafcillin—Body temperature increased—Cisplatin—hematologic cancer	8.81e-05	0.000296	CcSEcCtD
Nafcillin—Myalgia—Betamethasone—hematologic cancer	8.77e-05	0.000295	CcSEcCtD
Nafcillin—Myalgia—Dexamethasone—hematologic cancer	8.77e-05	0.000295	CcSEcCtD
Nafcillin—Stomatitis—Epirubicin—hematologic cancer	8.75e-05	0.000294	CcSEcCtD
Nafcillin—Vomiting—Thalidomide—hematologic cancer	8.74e-05	0.000294	CcSEcCtD
Nafcillin—Pain—Etoposide—hematologic cancer	8.73e-05	0.000294	CcSEcCtD
Nafcillin—Neutropenia—Doxorubicin—hematologic cancer	8.71e-05	0.000293	CcSEcCtD
Nafcillin—Rash—Thalidomide—hematologic cancer	8.67e-05	0.000291	CcSEcCtD
Nafcillin—Discomfort—Betamethasone—hematologic cancer	8.66e-05	0.000291	CcSEcCtD
Nafcillin—Discomfort—Dexamethasone—hematologic cancer	8.66e-05	0.000291	CcSEcCtD
Nafcillin—Dermatitis—Thalidomide—hematologic cancer	8.66e-05	0.000291	CcSEcCtD
Nafcillin—Diarrhoea—Vincristine—hematologic cancer	8.63e-05	0.00029	CcSEcCtD
Nafcillin—Pain—Prednisolone—hematologic cancer	8.61e-05	0.00029	CcSEcCtD
Nafcillin—Haematuria—Epirubicin—hematologic cancer	8.56e-05	0.000288	CcSEcCtD
Nafcillin—Pruritus—Gemcitabine—hematologic cancer	8.46e-05	0.000284	CcSEcCtD
Nafcillin—Nausea—Thiotepa—hematologic cancer	8.45e-05	0.000284	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	8.44e-05	0.000284	CcSEcCtD
Nafcillin—Feeling abnormal—Etoposide—hematologic cancer	8.42e-05	0.000283	CcSEcCtD
Nafcillin—Anaphylactic shock—Dexamethasone—hematologic cancer	8.41e-05	0.000283	CcSEcCtD
Nafcillin—Anaphylactic shock—Betamethasone—hematologic cancer	8.41e-05	0.000283	CcSEcCtD
Nafcillin—Diarrhoea—Irinotecan—hematologic cancer	8.4e-05	0.000282	CcSEcCtD
Nafcillin—Diarrhoea—Mitoxantrone—hematologic cancer	8.4e-05	0.000282	CcSEcCtD
Nafcillin—Vomiting—Carmustine—hematologic cancer	8.4e-05	0.000282	CcSEcCtD
Nafcillin—Agranulocytosis—Epirubicin—hematologic cancer	8.38e-05	0.000282	CcSEcCtD
Nafcillin—Gastrointestinal pain—Etoposide—hematologic cancer	8.35e-05	0.000281	CcSEcCtD
Nafcillin—Rash—Carmustine—hematologic cancer	8.33e-05	0.00028	CcSEcCtD
Nafcillin—Ill-defined disorder—Prednisone—hematologic cancer	8.32e-05	0.00028	CcSEcCtD
Nafcillin—Dermatitis—Carmustine—hematologic cancer	8.32e-05	0.00028	CcSEcCtD
Nafcillin—Vomiting—Alitretinoin—hematologic cancer	8.32e-05	0.00028	CcSEcCtD
Nafcillin—Feeling abnormal—Prednisolone—hematologic cancer	8.3e-05	0.000279	CcSEcCtD
Nafcillin—Shock—Dexamethasone—hematologic cancer	8.27e-05	0.000278	CcSEcCtD
Nafcillin—Shock—Betamethasone—hematologic cancer	8.27e-05	0.000278	CcSEcCtD
Nafcillin—Rash—Alitretinoin—hematologic cancer	8.25e-05	0.000277	CcSEcCtD
Nafcillin—Dermatitis—Alitretinoin—hematologic cancer	8.24e-05	0.000277	CcSEcCtD
Nafcillin—Vomiting—Ifosfamide—hematologic cancer	8.22e-05	0.000276	CcSEcCtD
Nafcillin—Hypersensitivity—Cisplatin—hematologic cancer	8.21e-05	0.000276	CcSEcCtD
Nafcillin—Angioedema—Prednisone—hematologic cancer	8.2e-05	0.000276	CcSEcCtD
Nafcillin—Diarrhoea—Gemcitabine—hematologic cancer	8.18e-05	0.000275	CcSEcCtD
Nafcillin—Nausea—Thalidomide—hematologic cancer	8.17e-05	0.000275	CcSEcCtD
Nafcillin—Renal failure—Doxorubicin—hematologic cancer	8.16e-05	0.000274	CcSEcCtD
Nafcillin—Rash—Ifosfamide—hematologic cancer	8.15e-05	0.000274	CcSEcCtD
Nafcillin—Dermatitis—Ifosfamide—hematologic cancer	8.15e-05	0.000274	CcSEcCtD
Nafcillin—Urticaria—Etoposide—hematologic cancer	8.11e-05	0.000273	CcSEcCtD
Nafcillin—Stomatitis—Doxorubicin—hematologic cancer	8.1e-05	0.000272	CcSEcCtD
Nafcillin—Malaise—Prednisone—hematologic cancer	8.09e-05	0.000272	CcSEcCtD
Nafcillin—Abdominal pain—Etoposide—hematologic cancer	8.07e-05	0.000271	CcSEcCtD
Nafcillin—Body temperature increased—Etoposide—hematologic cancer	8.07e-05	0.000271	CcSEcCtD
Nafcillin—Vomiting—Vincristine—hematologic cancer	8.02e-05	0.000269	CcSEcCtD
Nafcillin—Urticaria—Prednisolone—hematologic cancer	8e-05	0.000269	CcSEcCtD
Nafcillin—Rash—Vincristine—hematologic cancer	7.95e-05	0.000267	CcSEcCtD
Nafcillin—Dermatitis—Vincristine—hematologic cancer	7.94e-05	0.000267	CcSEcCtD
Nafcillin—Pain—Triamcinolone—hematologic cancer	7.92e-05	0.000266	CcSEcCtD
Nafcillin—Haematuria—Doxorubicin—hematologic cancer	7.92e-05	0.000266	CcSEcCtD
Nafcillin—Hypotension—Dexamethasone—hematologic cancer	7.85e-05	0.000264	CcSEcCtD
Nafcillin—Hypotension—Betamethasone—hematologic cancer	7.85e-05	0.000264	CcSEcCtD
Nafcillin—Nausea—Carmustine—hematologic cancer	7.84e-05	0.000264	CcSEcCtD
Nafcillin—Vomiting—Irinotecan—hematologic cancer	7.81e-05	0.000262	CcSEcCtD
Nafcillin—Vomiting—Mitoxantrone—hematologic cancer	7.81e-05	0.000262	CcSEcCtD
Nafcillin—Nausea—Alitretinoin—hematologic cancer	7.77e-05	0.000261	CcSEcCtD
Nafcillin—Agranulocytosis—Doxorubicin—hematologic cancer	7.75e-05	0.000261	CcSEcCtD
Nafcillin—Rash—Irinotecan—hematologic cancer	7.74e-05	0.00026	CcSEcCtD
Nafcillin—Rash—Mitoxantrone—hematologic cancer	7.74e-05	0.00026	CcSEcCtD
Nafcillin—Dermatitis—Mitoxantrone—hematologic cancer	7.73e-05	0.00026	CcSEcCtD
Nafcillin—Dermatitis—Irinotecan—hematologic cancer	7.73e-05	0.00026	CcSEcCtD
Nafcillin—Nausea—Ifosfamide—hematologic cancer	7.68e-05	0.000258	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	7.66e-05	0.000257	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	7.66e-05	0.000257	CcSEcCtD
Nafcillin—Myalgia—Prednisone—hematologic cancer	7.64e-05	0.000257	CcSEcCtD
Nafcillin—Arthralgia—Prednisone—hematologic cancer	7.64e-05	0.000257	CcSEcCtD
Nafcillin—Feeling abnormal—Triamcinolone—hematologic cancer	7.63e-05	0.000257	CcSEcCtD
Nafcillin—Diarrhoea—Cisplatin—hematologic cancer	7.63e-05	0.000256	CcSEcCtD
Nafcillin—Vomiting—Gemcitabine—hematologic cancer	7.6e-05	0.000256	CcSEcCtD
Nafcillin—Discomfort—Prednisone—hematologic cancer	7.54e-05	0.000254	CcSEcCtD
Nafcillin—Rash—Gemcitabine—hematologic cancer	7.54e-05	0.000254	CcSEcCtD
Nafcillin—Dermatitis—Gemcitabine—hematologic cancer	7.53e-05	0.000253	CcSEcCtD
Nafcillin—Hypersensitivity—Etoposide—hematologic cancer	7.52e-05	0.000253	CcSEcCtD
Nafcillin—Nausea—Vincristine—hematologic cancer	7.49e-05	0.000252	CcSEcCtD
Nafcillin—Hypersensitivity—Prednisolone—hematologic cancer	7.42e-05	0.00025	CcSEcCtD
Nafcillin—Urticaria—Triamcinolone—hematologic cancer	7.36e-05	0.000247	CcSEcCtD
Nafcillin—Body temperature increased—Triamcinolone—hematologic cancer	7.32e-05	0.000246	CcSEcCtD
Nafcillin—Anaphylactic shock—Prednisone—hematologic cancer	7.32e-05	0.000246	CcSEcCtD
Nafcillin—Nausea—Mitoxantrone—hematologic cancer	7.29e-05	0.000245	CcSEcCtD
Nafcillin—Nausea—Irinotecan—hematologic cancer	7.29e-05	0.000245	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Betamethasone—hematologic cancer	7.26e-05	0.000244	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	7.26e-05	0.000244	CcSEcCtD
Nafcillin—Pruritus—Etoposide—hematologic cancer	7.23e-05	0.000243	CcSEcCtD
Nafcillin—Shock—Prednisone—hematologic cancer	7.2e-05	0.000242	CcSEcCtD
Nafcillin—Pain—Betamethasone—hematologic cancer	7.19e-05	0.000242	CcSEcCtD
Nafcillin—Pain—Dexamethasone—hematologic cancer	7.19e-05	0.000242	CcSEcCtD
Nafcillin—Nausea—Gemcitabine—hematologic cancer	7.1e-05	0.000239	CcSEcCtD
Nafcillin—Vomiting—Cisplatin—hematologic cancer	7.09e-05	0.000238	CcSEcCtD
Nafcillin—Rash—Cisplatin—hematologic cancer	7.03e-05	0.000236	CcSEcCtD
Nafcillin—Dermatitis—Cisplatin—hematologic cancer	7.02e-05	0.000236	CcSEcCtD
Nafcillin—Diarrhoea—Etoposide—hematologic cancer	6.99e-05	0.000235	CcSEcCtD
Nafcillin—Ill-defined disorder—Methotrexate—hematologic cancer	6.95e-05	0.000234	CcSEcCtD
Nafcillin—Feeling abnormal—Dexamethasone—hematologic cancer	6.93e-05	0.000233	CcSEcCtD
Nafcillin—Feeling abnormal—Betamethasone—hematologic cancer	6.93e-05	0.000233	CcSEcCtD
Nafcillin—Gastrointestinal pain—Betamethasone—hematologic cancer	6.87e-05	0.000231	CcSEcCtD
Nafcillin—Gastrointestinal pain—Dexamethasone—hematologic cancer	6.87e-05	0.000231	CcSEcCtD
Nafcillin—Hypersensitivity—Triamcinolone—hematologic cancer	6.82e-05	0.000229	CcSEcCtD
Nafcillin—Malaise—Methotrexate—hematologic cancer	6.76e-05	0.000227	CcSEcCtD
Nafcillin—Urticaria—Dexamethasone—hematologic cancer	6.68e-05	0.000224	CcSEcCtD
Nafcillin—Urticaria—Betamethasone—hematologic cancer	6.68e-05	0.000224	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Prednisone—hematologic cancer	6.67e-05	0.000224	CcSEcCtD
Nafcillin—Body temperature increased—Dexamethasone—hematologic cancer	6.64e-05	0.000223	CcSEcCtD
Nafcillin—Body temperature increased—Betamethasone—hematologic cancer	6.64e-05	0.000223	CcSEcCtD
Nafcillin—Abdominal pain—Dexamethasone—hematologic cancer	6.64e-05	0.000223	CcSEcCtD
Nafcillin—Abdominal pain—Betamethasone—hematologic cancer	6.64e-05	0.000223	CcSEcCtD
Nafcillin—Nausea—Cisplatin—hematologic cancer	6.62e-05	0.000223	CcSEcCtD
Nafcillin—Pruritus—Triamcinolone—hematologic cancer	6.55e-05	0.00022	CcSEcCtD
Nafcillin—Ill-defined disorder—Epirubicin—hematologic cancer	6.51e-05	0.000219	CcSEcCtD
Nafcillin—Vomiting—Etoposide—hematologic cancer	6.49e-05	0.000218	CcSEcCtD
Nafcillin—Rash—Etoposide—hematologic cancer	6.44e-05	0.000216	CcSEcCtD
Nafcillin—Dermatitis—Etoposide—hematologic cancer	6.43e-05	0.000216	CcSEcCtD
Nafcillin—Myalgia—Methotrexate—hematologic cancer	6.38e-05	0.000215	CcSEcCtD
Nafcillin—Arthralgia—Methotrexate—hematologic cancer	6.38e-05	0.000215	CcSEcCtD
Nafcillin—Rash—Prednisolone—hematologic cancer	6.35e-05	0.000214	CcSEcCtD
Nafcillin—Dermatitis—Prednisolone—hematologic cancer	6.35e-05	0.000213	CcSEcCtD
Nafcillin—Malaise—Epirubicin—hematologic cancer	6.33e-05	0.000213	CcSEcCtD
Nafcillin—Discomfort—Methotrexate—hematologic cancer	6.3e-05	0.000212	CcSEcCtD
Nafcillin—Anaphylactic shock—Methotrexate—hematologic cancer	6.12e-05	0.000206	CcSEcCtD
Nafcillin—Nausea—Etoposide—hematologic cancer	6.07e-05	0.000204	CcSEcCtD
Nafcillin—Feeling abnormal—Prednisone—hematologic cancer	6.03e-05	0.000203	CcSEcCtD
Nafcillin—Ill-defined disorder—Doxorubicin—hematologic cancer	6.02e-05	0.000202	CcSEcCtD
Nafcillin—Gastrointestinal pain—Prednisone—hematologic cancer	5.99e-05	0.000201	CcSEcCtD
Nafcillin—Nausea—Prednisolone—hematologic cancer	5.98e-05	0.000201	CcSEcCtD
Nafcillin—Myalgia—Epirubicin—hematologic cancer	5.97e-05	0.000201	CcSEcCtD
Nafcillin—Arthralgia—Epirubicin—hematologic cancer	5.97e-05	0.000201	CcSEcCtD
Nafcillin—Pruritus—Betamethasone—hematologic cancer	5.95e-05	0.0002	CcSEcCtD
Nafcillin—Pruritus—Dexamethasone—hematologic cancer	5.95e-05	0.0002	CcSEcCtD
Nafcillin—Discomfort—Epirubicin—hematologic cancer	5.9e-05	0.000198	CcSEcCtD
Nafcillin—Vomiting—Triamcinolone—hematologic cancer	5.89e-05	0.000198	CcSEcCtD
Nafcillin—Malaise—Doxorubicin—hematologic cancer	5.85e-05	0.000197	CcSEcCtD
Nafcillin—Rash—Triamcinolone—hematologic cancer	5.84e-05	0.000196	CcSEcCtD
Nafcillin—Dermatitis—Triamcinolone—hematologic cancer	5.84e-05	0.000196	CcSEcCtD
Nafcillin—Urticaria—Prednisone—hematologic cancer	5.82e-05	0.000195	CcSEcCtD
Nafcillin—Abdominal pain—Prednisone—hematologic cancer	5.79e-05	0.000195	CcSEcCtD
Nafcillin—Body temperature increased—Prednisone—hematologic cancer	5.79e-05	0.000195	CcSEcCtD
Nafcillin—Diarrhoea—Dexamethasone—hematologic cancer	5.75e-05	0.000193	CcSEcCtD
Nafcillin—Diarrhoea—Betamethasone—hematologic cancer	5.75e-05	0.000193	CcSEcCtD
Nafcillin—Anaphylactic shock—Epirubicin—hematologic cancer	5.72e-05	0.000192	CcSEcCtD
Nafcillin—Hypotension—Methotrexate—hematologic cancer	5.72e-05	0.000192	CcSEcCtD
Nafcillin—Shock—Epirubicin—hematologic cancer	5.63e-05	0.000189	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	5.57e-05	0.000187	CcSEcCtD
Nafcillin—Myalgia—Doxorubicin—hematologic cancer	5.53e-05	0.000186	CcSEcCtD
Nafcillin—Arthralgia—Doxorubicin—hematologic cancer	5.53e-05	0.000186	CcSEcCtD
Nafcillin—Nausea—Triamcinolone—hematologic cancer	5.5e-05	0.000185	CcSEcCtD
Nafcillin—Discomfort—Doxorubicin—hematologic cancer	5.46e-05	0.000184	CcSEcCtD
Nafcillin—Hypersensitivity—Prednisone—hematologic cancer	5.39e-05	0.000181	CcSEcCtD
Nafcillin—Hypotension—Epirubicin—hematologic cancer	5.35e-05	0.00018	CcSEcCtD
Nafcillin—Vomiting—Dexamethasone—hematologic cancer	5.34e-05	0.00018	CcSEcCtD
Nafcillin—Vomiting—Betamethasone—hematologic cancer	5.34e-05	0.00018	CcSEcCtD
Nafcillin—Rash—Dexamethasone—hematologic cancer	5.3e-05	0.000178	CcSEcCtD
Nafcillin—Rash—Betamethasone—hematologic cancer	5.3e-05	0.000178	CcSEcCtD
Nafcillin—Anaphylactic shock—Doxorubicin—hematologic cancer	5.3e-05	0.000178	CcSEcCtD
Nafcillin—Dermatitis—Dexamethasone—hematologic cancer	5.29e-05	0.000178	CcSEcCtD
Nafcillin—Dermatitis—Betamethasone—hematologic cancer	5.29e-05	0.000178	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Methotrexate—hematologic cancer	5.28e-05	0.000178	CcSEcCtD
Nafcillin—Pain—Methotrexate—hematologic cancer	5.23e-05	0.000176	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	5.22e-05	0.000175	CcSEcCtD
Nafcillin—Shock—Doxorubicin—hematologic cancer	5.21e-05	0.000175	CcSEcCtD
Nafcillin—Pruritus—Prednisone—hematologic cancer	5.18e-05	0.000174	CcSEcCtD
Nafcillin—Feeling abnormal—Methotrexate—hematologic cancer	5.04e-05	0.000169	CcSEcCtD
Nafcillin—Diarrhoea—Prednisone—hematologic cancer	5.01e-05	0.000168	CcSEcCtD
Nafcillin—Gastrointestinal pain—Methotrexate—hematologic cancer	5e-05	0.000168	CcSEcCtD
Nafcillin—Nausea—Dexamethasone—hematologic cancer	4.99e-05	0.000168	CcSEcCtD
Nafcillin—Nausea—Betamethasone—hematologic cancer	4.99e-05	0.000168	CcSEcCtD
Nafcillin—Hypotension—Doxorubicin—hematologic cancer	4.95e-05	0.000166	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.94e-05	0.000166	CcSEcCtD
Nafcillin—Pain—Epirubicin—hematologic cancer	4.9e-05	0.000165	CcSEcCtD
Nafcillin—Urticaria—Methotrexate—hematologic cancer	4.86e-05	0.000163	CcSEcCtD
Nafcillin—Body temperature increased—Methotrexate—hematologic cancer	4.84e-05	0.000163	CcSEcCtD
Nafcillin—Abdominal pain—Methotrexate—hematologic cancer	4.84e-05	0.000163	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.83e-05	0.000162	CcSEcCtD
Nafcillin—Feeling abnormal—Epirubicin—hematologic cancer	4.72e-05	0.000159	CcSEcCtD
Nafcillin—Gastrointestinal pain—Epirubicin—hematologic cancer	4.68e-05	0.000157	CcSEcCtD
Nafcillin—Vomiting—Prednisone—hematologic cancer	4.65e-05	0.000156	CcSEcCtD
Nafcillin—Rash—Prednisone—hematologic cancer	4.62e-05	0.000155	CcSEcCtD
Nafcillin—Dermatitis—Prednisone—hematologic cancer	4.61e-05	0.000155	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.57e-05	0.000154	CcSEcCtD
Nafcillin—Urticaria—Epirubicin—hematologic cancer	4.55e-05	0.000153	CcSEcCtD
Nafcillin—Pain—Doxorubicin—hematologic cancer	4.53e-05	0.000152	CcSEcCtD
Nafcillin—Abdominal pain—Epirubicin—hematologic cancer	4.53e-05	0.000152	CcSEcCtD
Nafcillin—Body temperature increased—Epirubicin—hematologic cancer	4.53e-05	0.000152	CcSEcCtD
Nafcillin—Hypersensitivity—Methotrexate—hematologic cancer	4.51e-05	0.000152	CcSEcCtD
Nafcillin—Feeling abnormal—Doxorubicin—hematologic cancer	4.37e-05	0.000147	CcSEcCtD
Nafcillin—Nausea—Prednisone—hematologic cancer	4.35e-05	0.000146	CcSEcCtD
Nafcillin—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.33e-05	0.000146	CcSEcCtD
Nafcillin—Pruritus—Methotrexate—hematologic cancer	4.33e-05	0.000146	CcSEcCtD
Nafcillin—Hypersensitivity—Epirubicin—hematologic cancer	4.22e-05	0.000142	CcSEcCtD
Nafcillin—Urticaria—Doxorubicin—hematologic cancer	4.21e-05	0.000141	CcSEcCtD
Nafcillin—Abdominal pain—Doxorubicin—hematologic cancer	4.19e-05	0.000141	CcSEcCtD
Nafcillin—Body temperature increased—Doxorubicin—hematologic cancer	4.19e-05	0.000141	CcSEcCtD
Nafcillin—Diarrhoea—Methotrexate—hematologic cancer	4.19e-05	0.000141	CcSEcCtD
Nafcillin—Pruritus—Epirubicin—hematologic cancer	4.05e-05	0.000136	CcSEcCtD
Nafcillin—Diarrhoea—Epirubicin—hematologic cancer	3.92e-05	0.000132	CcSEcCtD
Nafcillin—Hypersensitivity—Doxorubicin—hematologic cancer	3.9e-05	0.000131	CcSEcCtD
Nafcillin—Vomiting—Methotrexate—hematologic cancer	3.89e-05	0.000131	CcSEcCtD
Nafcillin—Rash—Methotrexate—hematologic cancer	3.86e-05	0.00013	CcSEcCtD
Nafcillin—Dermatitis—Methotrexate—hematologic cancer	3.85e-05	0.00013	CcSEcCtD
Nafcillin—Pruritus—Doxorubicin—hematologic cancer	3.75e-05	0.000126	CcSEcCtD
Nafcillin—Vomiting—Epirubicin—hematologic cancer	3.64e-05	0.000122	CcSEcCtD
Nafcillin—Nausea—Methotrexate—hematologic cancer	3.63e-05	0.000122	CcSEcCtD
Nafcillin—Diarrhoea—Doxorubicin—hematologic cancer	3.62e-05	0.000122	CcSEcCtD
Nafcillin—Rash—Epirubicin—hematologic cancer	3.61e-05	0.000121	CcSEcCtD
Nafcillin—Dermatitis—Epirubicin—hematologic cancer	3.61e-05	0.000121	CcSEcCtD
Nafcillin—Nausea—Epirubicin—hematologic cancer	3.4e-05	0.000114	CcSEcCtD
Nafcillin—Vomiting—Doxorubicin—hematologic cancer	3.37e-05	0.000113	CcSEcCtD
Nafcillin—Rash—Doxorubicin—hematologic cancer	3.34e-05	0.000112	CcSEcCtD
Nafcillin—Dermatitis—Doxorubicin—hematologic cancer	3.34e-05	0.000112	CcSEcCtD
Nafcillin—Nausea—Doxorubicin—hematologic cancer	3.15e-05	0.000106	CcSEcCtD
Nafcillin—SLC22A6—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	1.9e-05	0.00782	CbGpPWpGaD
Nafcillin—CYP1A2—Estrogen Receptor Pathway—ESR1—hematologic cancer	1.9e-05	0.00781	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—NCOR2—hematologic cancer	1.89e-05	0.00777	CbGpPWpGaD
Nafcillin—CYP3A4—Estrogen metabolism—NQO1—hematologic cancer	1.88e-05	0.00771	CbGpPWpGaD
Nafcillin—CYP1A2—Estrogen metabolism—GSTM1—hematologic cancer	1.86e-05	0.00766	CbGpPWpGaD
Nafcillin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	1.84e-05	0.00755	CbGpPWpGaD
Nafcillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	1.75e-05	0.0072	CbGpPWpGaD
Nafcillin—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	1.73e-05	0.0071	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—NF1—hematologic cancer	1.71e-05	0.00702	CbGpPWpGaD
Nafcillin—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	1.69e-05	0.00697	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUND—hematologic cancer	1.67e-05	0.00688	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—UGT1A1—hematologic cancer	1.67e-05	0.00688	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—SLC35B2—hematologic cancer	1.64e-05	0.00676	CbGpPWpGaD
Nafcillin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—hematologic cancer	1.55e-05	0.00638	CbGpPWpGaD
Nafcillin—CYP1A2—Arachidonic acid metabolism—ALOX5—hematologic cancer	1.48e-05	0.00611	CbGpPWpGaD
Nafcillin—CYP3A4—Estrogen metabolism—GSTM1—hematologic cancer	1.44e-05	0.00591	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—AQP9—hematologic cancer	1.37e-05	0.00564	CbGpPWpGaD
Nafcillin—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	1.35e-05	0.00554	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—FXYD6—hematologic cancer	1.28e-05	0.00524	CbGpPWpGaD
Nafcillin—CYP1A2—Melatonin metabolism and effects—FOXO1—hematologic cancer	1.24e-05	0.0051	CbGpPWpGaD
Nafcillin—CYP1A2—Estrogen Receptor Pathway—JUN—hematologic cancer	1.23e-05	0.00505	CbGpPWpGaD
Nafcillin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	1.15e-05	0.00474	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—hematologic cancer	1.15e-05	0.00472	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—hematologic cancer	1.15e-05	0.00472	CbGpPWpGaD
Nafcillin—SLC22A6—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	1.12e-05	0.00461	CbGpPWpGaD
Nafcillin—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	1.11e-05	0.00458	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HSP90AA1—hematologic cancer	1.08e-05	0.00444	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—HSP90AA1—hematologic cancer	1.08e-05	0.00444	CbGpPWpGaD
Nafcillin—CYP1A2—Estrogen Receptor Pathway—STAT3—hematologic cancer	1.06e-05	0.00437	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—GSTO1—hematologic cancer	1.06e-05	0.00436	CbGpPWpGaD
Nafcillin—SLC22A6—SLC-mediated transmembrane transport—NUP98—hematologic cancer	1.06e-05	0.00435	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—S100A10—hematologic cancer	1.04e-05	0.00427	CbGpPWpGaD
Nafcillin—SLC22A6—SLC-mediated transmembrane transport—NUP214—hematologic cancer	1.02e-05	0.00419	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—UGT1A1—hematologic cancer	9.96e-06	0.0041	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	9.66e-06	0.00397	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—SLC35B2—hematologic cancer	9.62e-06	0.00396	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—EPHX1—hematologic cancer	9.49e-06	0.0039	CbGpPWpGaD
Nafcillin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	9.35e-06	0.00384	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	9.09e-06	0.00374	CbGpPWpGaD
Nafcillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	8.91e-06	0.00366	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—hematologic cancer	8.85e-06	0.00364	CbGpPWpGaD
Nafcillin—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	8.84e-06	0.00364	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—MTR—hematologic cancer	8.64e-06	0.00355	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	8.61e-06	0.00354	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—hematologic cancer	8.57e-06	0.00352	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—GSTT1—hematologic cancer	8.22e-06	0.00338	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—SGK1—hematologic cancer	7.88e-06	0.00324	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ATP4A—hematologic cancer	7.88e-06	0.00324	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ANXA2—hematologic cancer	7.88e-06	0.00324	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	7.43e-06	0.00305	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—hematologic cancer	7.34e-06	0.00302	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	7.32e-06	0.00301	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	7.09e-06	0.00292	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—hematologic cancer	6.91e-06	0.00284	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ABCC3—hematologic cancer	6.23e-06	0.00256	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTO1—hematologic cancer	6.2e-06	0.00255	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—GSTO1—hematologic cancer	6.12e-06	0.00251	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—hematologic cancer	6.03e-06	0.00248	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—UGT1A1—hematologic cancer	5.83e-06	0.0024	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—hematologic cancer	5.78e-06	0.00238	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—UGT1A1—hematologic cancer	5.75e-06	0.00236	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	5.73e-06	0.00236	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—GSTP1—hematologic cancer	5.7e-06	0.00234	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	5.69e-06	0.00234	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—NUP98—hematologic cancer	5.37e-06	0.00221	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	5.24e-06	0.00216	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—GSTM1—hematologic cancer	5.23e-06	0.00215	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ADCY7—hematologic cancer	5.22e-06	0.00215	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—NUP214—hematologic cancer	5.18e-06	0.00213	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hematologic cancer	5.17e-06	0.00213	CbGpPWpGaD
Nafcillin—CYP1A2—Tryptophan metabolism—MDM2—hematologic cancer	5.14e-06	0.00211	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ABCG2—hematologic cancer	5.08e-06	0.00209	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—MTR—hematologic cancer	5.05e-06	0.00208	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTT1—hematologic cancer	4.81e-06	0.00198	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	4.79e-06	0.00197	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	4.72e-06	0.00194	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—hematologic cancer	4.7e-06	0.00193	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—hematologic cancer	4.7e-06	0.00193	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—hematologic cancer	4.61e-06	0.0019	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hematologic cancer	4.6e-06	0.00189	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—TFRC—hematologic cancer	4.52e-06	0.00186	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	4.5e-06	0.00185	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—hematologic cancer	4.47e-06	0.00184	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	4.44e-06	0.00182	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hematologic cancer	4.33e-06	0.00178	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—hematologic cancer	4.12e-06	0.0017	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—hematologic cancer	4.12e-06	0.0017	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—hematologic cancer	4.01e-06	0.00165	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—hematologic cancer	4.01e-06	0.00165	CbGpPWpGaD
Nafcillin—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	3.97e-06	0.00163	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—hematologic cancer	3.91e-06	0.00161	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—MTR—hematologic cancer	3.9e-06	0.0016	CbGpPWpGaD
Nafcillin—SLC22A6—SLC-mediated transmembrane transport—ALB—hematologic cancer	3.9e-06	0.0016	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—hematologic cancer	3.86e-06	0.00159	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.8e-06	0.00156	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	3.71e-06	0.00153	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	3.69e-06	0.00152	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—hematologic cancer	3.59e-06	0.00148	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hematologic cancer	3.58e-06	0.00147	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hematologic cancer	3.35e-06	0.00138	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hematologic cancer	3.35e-06	0.00138	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTP1—hematologic cancer	3.33e-06	0.00137	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—hematologic cancer	3.32e-06	0.00137	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—GSTP1—hematologic cancer	3.29e-06	0.00135	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.17e-06	0.0013	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTM1—hematologic cancer	3.06e-06	0.00126	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—GSTM1—hematologic cancer	3.02e-06	0.00124	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	3.01e-06	0.00124	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—hematologic cancer	2.82e-06	0.00116	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	2.63e-06	0.00108	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	2.57e-06	0.00106	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GMPS—hematologic cancer	2.55e-06	0.00105	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—FTCD—hematologic cancer	2.55e-06	0.00105	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PHYH—hematologic cancer	2.55e-06	0.00105	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	2.54e-06	0.00104	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	2.53e-06	0.00104	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	2.41e-06	0.00099	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	2.38e-06	0.000979	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	2.36e-06	0.000972	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—SMPD3—hematologic cancer	2.34e-06	0.00096	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	2.33e-06	0.000958	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	2.33e-06	0.000958	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.18e-06	0.000895	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.12e-06	0.000873	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.12e-06	0.000871	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ASNS—hematologic cancer	2.04e-06	0.000839	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—DCK—hematologic cancer	2.04e-06	0.000839	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—B3GAT1—hematologic cancer	2.04e-06	0.000839	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2e-06	0.00082	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	1.98e-06	0.000815	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—FTCD—hematologic cancer	1.97e-06	0.00081	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PHYH—hematologic cancer	1.97e-06	0.00081	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GMPS—hematologic cancer	1.97e-06	0.00081	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—HDC—hematologic cancer	1.94e-06	0.000796	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.8e-06	0.000742	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.8e-06	0.000741	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CDA—hematologic cancer	1.77e-06	0.000728	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PC—hematologic cancer	1.7e-06	0.000701	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GBA—hematologic cancer	1.65e-06	0.000677	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—SLC35B2—hematologic cancer	1.65e-06	0.000677	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.58e-06	0.000648	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—DCK—hematologic cancer	1.58e-06	0.000648	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ASNS—hematologic cancer	1.58e-06	0.000648	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—MTAP—hematologic cancer	1.5e-06	0.000619	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—HDC—hematologic cancer	1.49e-06	0.000614	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CDA—hematologic cancer	1.37e-06	0.000562	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—FHL2—hematologic cancer	1.34e-06	0.000552	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—AGRN—hematologic cancer	1.32e-06	0.000541	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PC—hematologic cancer	1.31e-06	0.000541	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GBA—hematologic cancer	1.27e-06	0.000522	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.27e-06	0.000522	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—IDH2—hematologic cancer	1.25e-06	0.000513	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—HMMR—hematologic cancer	1.25e-06	0.000513	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.18e-06	0.000483	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ARNTL—hematologic cancer	1.17e-06	0.000482	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—MTAP—hematologic cancer	1.16e-06	0.000478	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ACP5—hematologic cancer	1.14e-06	0.000469	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CA9—hematologic cancer	1.14e-06	0.000469	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NCOR2—hematologic cancer	1.13e-06	0.000463	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—IDH1—hematologic cancer	1.07e-06	0.000441	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—TXN—hematologic cancer	1.06e-06	0.000436	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTO1—hematologic cancer	1.06e-06	0.000436	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ABCC3—hematologic cancer	1.06e-06	0.000436	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—SPHK1—hematologic cancer	1.04e-06	0.000427	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—FHL2—hematologic cancer	1.04e-06	0.000426	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—AGRN—hematologic cancer	1.02e-06	0.000417	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—UGT1A1—hematologic cancer	9.97e-07	0.00041	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—SLC22A1—hematologic cancer	9.7e-07	0.000399	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CRABP1—hematologic cancer	9.7e-07	0.000399	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—HMMR—hematologic cancer	9.62e-07	0.000396	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—IDH2—hematologic cancer	9.62e-07	0.000396	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ALOX5—hematologic cancer	9.45e-07	0.000389	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NUP98—hematologic cancer	9.15e-07	0.000376	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ARNTL—hematologic cancer	9.05e-07	0.000372	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ADCY7—hematologic cancer	8.89e-07	0.000365	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NCOA3—hematologic cancer	8.89e-07	0.000365	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NUP214—hematologic cancer	8.82e-07	0.000363	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CA9—hematologic cancer	8.8e-07	0.000362	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ACP5—hematologic cancer	8.8e-07	0.000362	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.73e-07	0.000359	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NCOR2—hematologic cancer	8.69e-07	0.000357	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ABCG2—hematologic cancer	8.64e-07	0.000355	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—MTR—hematologic cancer	8.64e-07	0.000355	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ENO2—hematologic cancer	8.48e-07	0.000349	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—IDH1—hematologic cancer	8.28e-07	0.00034	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTT1—hematologic cancer	8.22e-07	0.000338	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTO1—hematologic cancer	8.18e-07	0.000336	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—TXN—hematologic cancer	8.18e-07	0.000336	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ABCC3—hematologic cancer	8.18e-07	0.000336	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.1e-07	0.000333	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—SDC1—hematologic cancer	8.04e-07	0.00033	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—SPHK1—hematologic cancer	8.01e-07	0.000329	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—UGT1A1—hematologic cancer	7.69e-07	0.000316	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.68e-07	0.000316	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.58e-07	0.000312	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CRABP1—hematologic cancer	7.48e-07	0.000308	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—SLC22A1—hematologic cancer	7.48e-07	0.000308	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ALOX5—hematologic cancer	7.29e-07	0.0003	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.25e-07	0.000298	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NUP98—hematologic cancer	7.06e-07	0.00029	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.86e-07	0.000282	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.86e-07	0.000282	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CD44—hematologic cancer	6.83e-07	0.000281	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NQO1—hematologic cancer	6.83e-07	0.000281	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NUP214—hematologic cancer	6.81e-07	0.00028	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.69e-07	0.000275	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ABCG2—hematologic cancer	6.67e-07	0.000274	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—MTR—hematologic cancer	6.67e-07	0.000274	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ENO2—hematologic cancer	6.54e-07	0.000269	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYCS—hematologic cancer	6.47e-07	0.000266	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	6.42e-07	0.000264	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTT1—hematologic cancer	6.35e-07	0.000261	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—SDC1—hematologic cancer	6.2e-07	0.000255	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.78e-07	0.000238	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTP1—hematologic cancer	5.7e-07	0.000234	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.51e-07	0.000227	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ABCB1—hematologic cancer	5.39e-07	0.000222	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CD44—hematologic cancer	5.27e-07	0.000217	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NQO1—hematologic cancer	5.27e-07	0.000217	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NCOR1—hematologic cancer	5.24e-07	0.000215	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTM1—hematologic cancer	5.24e-07	0.000215	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYCS—hematologic cancer	4.99e-07	0.000205	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.96e-07	0.000204	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—MTHFR—hematologic cancer	4.63e-07	0.00019	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.4e-07	0.000181	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ABCB1—hematologic cancer	4.16e-07	0.000171	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.08e-07	0.000168	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTM1—hematologic cancer	4.04e-07	0.000166	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NCOR1—hematologic cancer	4.04e-07	0.000166	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PIK3CG—hematologic cancer	3.89e-07	0.00016	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CREBBP—hematologic cancer	3.61e-07	0.000148	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.57e-07	0.000147	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PIK3CD—hematologic cancer	3.42e-07	0.000141	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ALB—hematologic cancer	3.37e-07	0.000139	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PIK3R1—hematologic cancer	3.23e-07	0.000133	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3e-07	0.000123	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.98e-07	0.000123	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.78e-07	0.000114	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.64e-07	0.000108	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ALB—hematologic cancer	2.6e-07	0.000107	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PTEN—hematologic cancer	2.57e-07	0.000106	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.49e-07	0.000102	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—EP300—hematologic cancer	2.46e-07	0.000101	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.3e-07	9.46e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PTEN—hematologic cancer	1.99e-07	8.17e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—EP300—hematologic cancer	1.9e-07	7.79e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.82e-07	7.47e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—AKT1—hematologic cancer	1.48e-07	6.1e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.4e-07	5.76e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—AKT1—hematologic cancer	1.15e-07	4.71e-05	CbGpPWpGaD
